The Effectiveness of SGLT-2 Inhibitors vs GLP-1 Receptor Agonists in Enhancing Kidney Function and Glycemic Control for Diabetes Mellitus Patients with CKD: A Narrative Review
Introdution: Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) are highly interconnected, impacting global health. Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) offer promising benefits for glycemic control, cardiovascular...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Babali Health
2026-01-01
|
| Col·lecció: | Babali Nursing Research |
| Matèries: | |
| Accés en línia: | http://babalinursingresearch.com/index.php/BNR/article/view/506 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|